Furiex Pharmaceuticals is a drug development collaboration company which engages in the compound partnering business.
Business Model:
Revenue: $71M
Employees: 11-50
Furiex Pharmaceuticals was acquired by
Forest Laboratories.
The acquisition happend on 2014-04-28.
Details of the transaction were not public
Address: 3900 Paramount Pkwy
City: Morrisville
State: NC
Zip: 27560
Country: US
Furiex Pharmaceuticals is a drug development collaboration company which engages in the compound partnering business.
Contact Phone:
+19194567800
Contact Email:
Listed Exchange:
NASDAQ
IPO Date:
6/11/2010
Ticker Symbol:
FURX
Opened: -/share
EBITDA | - |
Total Cash | - |
Total Debt | - |
Total Revenue | - |
Total Profit (Gross) | - |
PE Ratio | - |
Announced Date | Company | Transaction | Money Raised |
---|
Announced Date | Transaction | Number of Investors | Money Raised | Lead Investors | 6/2012 | Unattributed | $7M |
Invus Public Equities |
8/2011 | Debt | $10M |
MidCap Financial LLC Silicon Valley Bank |
10/2013 | Post-IPO Debt | 1 | $15M |
Fred Eshelman Fred Eshelman |
1/2010 | Angel | $31M |
Fred Eshelman |
---|
Announced Date | Name | Price |
---|
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|